TY - JOUR A1 - von Jagow, Gerhard A1 - Sebald, Walter T1 - b-Type cytochromes N2 - No abstract available KW - Biochemie Y1 - 1980 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-47383 ER - TY - JOUR A1 - Brenner, Daniela A1 - Geiger, Nina A1 - Schlegel, Jan A1 - Diesendorf, Viktoria A1 - Kersting, Louise A1 - Fink, Julian A1 - Stelz, Linda A1 - Schneider-Schaulies, Sibylle A1 - Sauer, Markus A1 - Bodem, Jochen A1 - Seibel, Jürgen T1 - Azido-ceramides, a tool to analyse SARS-CoV-2 replication and inhibition — SARS-CoV-2 is inhibited by ceramides JF - International Journal of Molecular Sciences N2 - Recently, we have shown that C6-ceramides efficiently suppress viral replication by trapping the virus in lysosomes. Here, we use antiviral assays to evaluate a synthetic ceramide derivative α-NH2-ω-N3-C6-ceramide (AKS461) and to confirm the biological activity of C6-ceramides inhibiting SARS-CoV-2. Click-labeling with a fluorophore demonstrated that AKS461 accumulates in lysosomes. Previously, it has been shown that suppression of SARS-CoV-2 replication can be cell-type specific. Thus, AKS461 inhibited SARS-CoV-2 replication in Huh-7, Vero, and Calu-3 cells up to 2.5 orders of magnitude. The results were confirmed by CoronaFISH, indicating that AKS461 acts comparable to the unmodified C6-ceramide. Thus, AKS461 serves as a tool to study ceramide-associated cellular and viral pathways, such as SARS-CoV-2 infections, and it helped to identify lysosomes as the central organelle of C6-ceramides to inhibit viral replication. KW - ceramides KW - SARS-CoV-2 KW - azido-ceramides KW - sphingolipids Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-313581 SN - 1422-0067 VL - 24 IS - 8 ER - TY - JOUR A1 - Arenas, Andrés A1 - Roces, Flavio T1 - Avoidance of plants unsuitable for the symbiotic fungus in leaf-cutting ants: Learning can take place entirely at the colony dump JF - PLoS ONE N2 - Plants initially accepted by foraging leaf-cutting ants are later avoided if they prove unsuitable for their symbiotic fungus. Plant avoidance is mediated by the waste produced in the fungus garden soon after the incorporation of the unsuitable leaves, as foragers can learn plant odors and cues from the damaged fungus that are both present in the recently produced waste particles. We asked whether avoidance learning of plants unsuitable for the symbiotic fungus can take place entirely at the colony dump. In order to investigate whether cues available in the waste chamber induce plant avoidance in naïve subcolonies, we exchanged the waste produced by subcolonies fed either fungicide-treated privet leaves or untreated leaves and measured the acceptance of untreated privet leaves before and after the exchange of waste. Second, we evaluated whether foragers could perceive the avoidance cues directly at the dump by quantifying the visits of labeled foragers to the waste chamber. Finally, we asked whether foragers learn to specifically avoid untreated leaves of a plant after a confinement over 3 hours in the dump of subcolonies that were previously fed fungicide-treated leaves of that species. After the exchange of the waste chambers, workers from subcolonies that had access to waste from fungicide-treated privet leaves learned to avoid that plant. One-third of the labeled foragers visited the dump. Furthermore, naïve foragers learned to avoid a specific, previously unsuitable plant if exposed solely to cues of the dump during confinement. We suggest that cues at the dump enable foragers to predict the unsuitable effects of plants even if they had never been experienced in the fungus garden. KW - leaves KW - ants KW - fungi KW - foraging KW - animal sociality KW - social systems KW - learning KW - symbiosis Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-157559 VL - 12 IS - 3 ER - TY - JOUR A1 - Paponov, Ivan A. A1 - Dindas , Julian A1 - Król , Elżbieta A1 - Friz, Tatyana A1 - Budnyk, Vadym A1 - Teale, William A1 - Paponov, Martina A1 - Hedrich , Rainer A1 - Palme, Klaus T1 - Auxin-Induced plasma membrane depolarization is regulated by Auxin transport and not by AUXIN BINDING PROTEIN1 JF - Frontiers in Plant Science N2 - Auxin is a molecule, which controls many aspects of plant development through both transcriptional and non-transcriptional signaling responses. AUXIN BINDING PROTEIN1 (ABP1) is a putative receptor for rapid non-transcriptional auxin-induced changes in plasma membrane depolarization and endocytosis rates. However, the mechanism of ABP1-mediated signaling is poorly understood. Here we show that membrane depolarization and endocytosis inhibition are ABP1-independent responses and that auxin-induced plasma membrane depolarization is instead dependent on the auxin influx carrier AUX1. AUX1 was itself not involved in the regulation of endocytosis. Auxin-dependent depolarization of the plasma membrane was also modulated by the auxin efflux carrier PIN2. These data establish a new connection between auxin transport and non-transcriptional auxin signaling. KW - auxin KW - ABP1 KW - plasma membrane depolarization KW - AUX1 KW - endocytosis Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-195914 SN - 1664-462X VL - 9 ER - TY - JOUR A1 - Mainz, Laura A1 - Sarhan, Mohamed A. F. E. A1 - Roth, Sabine A1 - Sauer, Ursula A1 - Maurus, Katja A1 - Hartmann, Elena M. A1 - Seibert, Helen-Desiree A1 - Rosenwald, Andreas A1 - Diefenbacher, Markus E. A1 - Rosenfeldt, Mathias T. T1 - Autophagy blockage reduces the incidence of pancreatic ductal adenocarcinoma in the context of mutant Trp53 JF - Frontiers in Cell and Developmental Biology N2 - Macroautophagy (hereafter referred to as autophagy) is a homeostatic process that preserves cellular integrity. In mice, autophagy regulates pancreatic ductal adenocarcinoma (PDAC) development in a manner dependent on the status of the tumor suppressor gene Trp53. Studies published so far have investigated the impact of autophagy blockage in tumors arising from Trp53-hemizygous or -homozygous tissue. In contrast, in human PDACs the tumor suppressor gene TP53 is mutated rather than allelically lost, and TP53 mutants retain pathobiological functions that differ from complete allelic loss. In order to better represent the patient situation, we have investigated PDAC development in a well-characterized genetically engineered mouse model (GEMM) of PDAC with mutant Trp53 (Trp53\(^{R172H}\)) and deletion of the essential autophagy gene Atg7. Autophagy blockage reduced PDAC incidence but had no impact on survival time in the subset of animals that formed a tumor. In the absence of Atg7, non-tumor-bearing mice reached a similar age as animals with malignant disease. However, the architecture of autophagy-deficient, tumor-free pancreata was effaced, normal acinar tissue was largely replaced with low-grade pancreatic intraepithelial neoplasias (PanINs) and insulin expressing islet β-cells were reduced. Our data add further complexity to the interplay between Atg7 inhibition and Trp53 status in tumorigenesis. KW - pancreatic cancer KW - autophagy KW - p53 KW - metastasis KW - ATG7 Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-266005 SN - 2296-634X VL - 10 ER - TY - JOUR A1 - Kaltdorf, Kristin Verena A1 - Theiss, Maria A1 - Markert, Sebastian Matthias A1 - Zhen, Mei A1 - Dandekar, Thomas A1 - Stigloher, Christian A1 - Kollmannsberger, Philipp T1 - Automated classification of synaptic vesicles in electron tomograms of C. elegans using machine learning JF - PLoS ONE N2 - Synaptic vesicles (SVs) are a key component of neuronal signaling and fulfil different roles depending on their composition. In electron micrograms of neurites, two types of vesicles can be distinguished by morphological criteria, the classical “clear core” vesicles (CCV) and the typically larger “dense core” vesicles (DCV), with differences in electron density due to their diverse cargos. Compared to CCVs, the precise function of DCVs is less defined. DCVs are known to store neuropeptides, which function as neuronal messengers and modulators [1]. In C. elegans, they play a role in locomotion, dauer formation, egg-laying, and mechano- and chemosensation [2]. Another type of DCVs, also referred to as granulated vesicles, are known to transport Bassoon, Piccolo and further constituents of the presynaptic density in the center of the active zone (AZ), and therefore are important for synaptogenesis [3]. To better understand the role of different types of SVs, we present here a new automated approach to classify vesicles. We combine machine learning with an extension of our previously developed vesicle segmentation workflow, the ImageJ macro 3D ART VeSElecT. With that we reliably distinguish CCVs and DCVs in electron tomograms of C. elegans NMJs using image-based features. Analysis of the underlying ground truth data shows an increased fraction of DCVs as well as a higher mean distance between DCVs and AZs in dauer larvae compared to young adult hermaphrodites. Our machine learning based tools are adaptable and can be applied to study properties of different synaptic vesicle pools in electron tomograms of diverse model organisms. KW - synaptic vesicles KW - Caenorhabditis elegans KW - machine learning Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-176831 VL - 13 IS - 10 ER - TY - JOUR A1 - Malitschek, Barbara A1 - Wittbrodt, Joachim A1 - Fischer, Petra A1 - Lammers, Reiner A1 - Ullrich, Axel A1 - Schartl, Manfred T1 - Autocrine stimulation of the Xmrk receptor tyrosine kinase in Xiphophorus melanoma cells and identification of a source for the physiological ligand N2 - The melanoma·inducing gene of Xiphophorus fish encodes the Xmrk receptor tyrosine kinase. U sing a highly specific antiserum p~oduced against the recombinant receptor expressed with a baculovirus, it is shown that Xmrk is the most abundant phosphotyrosine protein in fish melanoma and thus highly activated in the tumors. Studies on a melanoma cellline revealed that these cells produce an activity that considerably stimulates receptor autophosphorylation. The stimulating activity induces receptor down-regulation and can be depleted from the melanoma cellsupernatant by the immobilized recombinant receptor protein. The fish melanoma cells can thus be considered autocrine tumor cells providing a source for future purification and characterization of the Xmrk ligand. KW - Physiologische Chemie Y1 - 1994 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-61551 ER - TY - THES A1 - Grimm, Johannes T1 - Autocrine and paracrine effects of BRAF inhibitor induced senescence in melanoma T1 - Autokrine und parakrine Effekte BRAF-Inhibitor-induzierter Seneszenz im Melanom N2 - The FDA approval of targeted therapy with BRAFV600E inhibitors like vemurafenib and dabrafenib in 2011 has been the first major breakthrough in the treatment of metastatic melanoma since almost three decades. Despite increased progression free survival and elevated overall survival rates, complete responses are scarce due to resistance development approximately six months after the initial drug treatment. It was previously shown in our group that melanoma cells under vemurafenib pressure in vitro and in vivo exhibit features of drug-induced senescence. It is known that some cell types, which undergo this cell cycle arrest, develop a so-called senescence associated secretome and it has been reported that melanoma cell lines also upregulate the expression of different factors after senescence induction. This work describes the effect of the vemurafenib-induced secretome on cells. Conditioned supernatants of vemurafenib-treated cells increased the viability of naive fibroblast and melanoma cell lines. RNA analysis of donor melanoma cells revealed elevated transcriptional levels of FGF1, MMP2 and CCL2 in the majority of tested cell lines under vemurafenib pressure, and I could confirm the secretion of functional proteins. Similar observations were also done after MEK inhibition as well as in a combined BRAF and MEK inhibitor treatment situation. Interestingly, the transcription of other FGF ligands (FGF7, FGF17) was also elevated after MEK/ERK1/2 inhibition. As FGF receptors are therapeutically relevant, I focused on the analysis of FGFR-dependent processes in response to BRAF inhibition. Recombinant FGF1 increased the survival rate of melanoma cells under vemurafenib pressure, while inhibition of the FGFR pathway diminished the viability of melanoma cells in combination with vemurafenib and blocked the stimulatory effect of vemurafenib conditioned medium. The BRAF inhibitor induced secretome is regulated by active PI3K/AKT signaling, and the joint inhibition of mTor and BRAFV600E led to decreased senescence induction and to a diminished induction of the secretome-associated genes. In parallel, combined inhibition of MEK and PI3K also drastically decreased mRNA levels of the relevant secretome components back to basal levels. In summary, I could demonstrate that BRAF inhibitor treated melanoma cell lines acquire a specific PI3K/AKT dependent secretome, which is characterized by FGF1, CCL2 and MMP2. This secretome is able to stimulate other cells such as naive melanoma cells and fibroblasts and contributes to a better survival under drug pressure. These data are therapeutically highly relevant, as they imply the usage of novel drug combinations, especially specific FGFR inhibitors, with BRAF inhibitors in the clinic. N2 - Die Zulassung der spezifischen BRAFV600E Inhibitoren Vemurafenib und Dabrafenib im Jahr 2011 war der erste wirksame Schritt nach Jahrzehnten der Stagnation in der Behandlung des metastasierenden Melanoms. Allerdings zeigte sich, dass trotz erhöhter Gesamtüberlebensrate und gestiegenem progressionsfreien Überleben komplette Remissionen selten waren. Wir konnten in vorangegangenen Versuchen zeigen, dass eine Behandlung BRAFV600E-mutierter Melanom Zelllinien mit Vemurafenib mit der Induktion von Seneszenz-assoziierten Merkmalen einhergeht. Da bekannt ist, dass seneszente Zellen, darunter auch Melanom Zellen, ein sogenanntes Sekretom ausbilden können, welches andere Zellen beeinflussen kann, war die Identifizierung und Charakterisierung von Vemurafenib-induzierten sezernierten Faktoren das Ziel meiner Arbeit. Initiale Versuche zeigten, dass konditionierter Überstand von Vemurafenib behandelten Zellen das Wachstum naiver Zelllinien erhöhen kann. Ich konnte in weiteren Versuchen zeigen, dass sich die Transkription und Expression des Cytokins CCL2, der Matrixmetalloprotease MMP2 und des Wachstumsfaktors FGF1 nach Vemurafenib Behandlung erhöht. Darüber hinaus konnte ich interessanterweise auch eine gesteigerte Transkription anderer FGF Liganden (FGF7, FGF17) feststellen, was meinen Fokus auf die Analyse von FGFR abhängigen Prozessen als Antwort auf die BRAF Inhibition gelenkt hat. Es zeigte sich, dass sich Melanomzellen mittels Zugabe von FGF1 besser gegen die Vemurafenib-induzierte MEK/ERK1/2 Hemmung behaupten können. Darüber hinaus konnte durch den Einsatz eines spezifischen FGFR Inhibitors die Viabilität von Melanomzellen unter Vemurafenib Behandlung vermindert werden. Auch der stimulierende Effekt des Vemurafenib konditionierten Überstandes konnte dadurch teilweise aufgehoben werden. Die Induktion des BRAF Inhibitor assoziierten Sekretoms ist auf einen aktiven PI3K/AKT Signalweg angewiesen. So führt eine gleichzeitige Hemmung des MEK/ERK1/2 und PI3K/AKT Signalwegs zu einer verminderten Seneszenzinduktion und einer niedrigeren Transkription der Seneszenz-assoziierten Gene. Zudem konnte ich feststellen, dass auch eine gemeinsame Hemmung von BRAF und MEK Seneszenz und das damit einhergehende Sekretom unter Beteiligung von CCL2, MMP2 und den FGFs induziert. Zusammenfassend zeigen meine Daten, dass BRAFV600E-mutierte Melanomzellen nach Vemurafenib Behandlung ein Sekretom ausbilden, welches potentiell wachstumsfördernde und matrix-modellierende Faktoren beinhaltet. Dies ist abhängig vom PI3K/AKT Signalweg und charakterisiert durch die Sekretion von FGF1, CCL2 und MMP2. Klinische Relevanz erlangen diese Erkenntnisse durch die Möglichkeit, diese Faktoren im Rahmen einer Kombinationstherapie, z.B. mit einem spezifischen FGFR Inhibitor, zu inaktivieren. KW - Melanoma KW - Inhibitor KW - Melanom Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-181161 ER - TY - JOUR A1 - Reimer, Georg A1 - Rose, Kathleen M. A1 - Scheer, Ulrich A1 - Tan, Eng M. T1 - Autoantibody to RNA polymerase I in scleroderma sera N2 - Autoantibodies to components of the nucleolus are a unique serological feature of patients with scleroderma. There are autoantibodies of several specificities; one type produces a speckled pattern of nucleolar staining in immunofluorescence. In actinomycin D and 5,6-dichloro-{j-D-ribofuranosylbenzimidazoletreated Vero cells, staining was restricted to the fibrillar and not the granular regions. By double immunofluorescence, specific rabbit anti-RNA polymerase I antibodies stained the same fibrillar structures in drug-segregated nucleoli as scleroderma sera. Scleroderma sera immunoprecipitated 13 polypeptides from (35S)methionine-labeled HeLa cell extract with molecular weights ranging from 210,000 to 14,000. Similar polypeptides were precipitated by rabbit anti-RNA polymerase I antibodies, and their common identities were confirmed in immunoabsorption experiments. Microinjection of purified IgG from a patient with speckled nucleolar staining effectively inhibited ribosomal RNA transcription. Autoantibodies to RNA polymerase I were restricted to certain patients with scleroderma and were not found in other autoimmune diseases. Y1 - 1987 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-34294 ER - TY - JOUR A1 - Schmitt, Jana A1 - Keller, Andreas A1 - Nourkami-Tutdibi, Nasenien A1 - Heisel, Sabrina A1 - Habel, Nunja A1 - Leidinger, Petra A1 - Ludwig, Nicole A1 - Gessler, Manfred A1 - Graf, Norbert A1 - Berthold, Frank A1 - Lenhof, Hans-Peter A1 - Meese, Eckart T1 - Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients JF - PLoS ONE N2 - Several studies report autoantibody signatures in cancer. The majority of these studies analyzed adult tumors and compared the seroreactivity pattern of tumor patients with the pattern in healthy controls. Here, we compared the autoimmune response in patients with neuroblastoma and patients with Wilms tumor representing two different childhood tumors. We were able to differentiate untreated neuroblastoma patients from untreated Wilms tumor patients with an accuracy of 86.8%, a sensitivity of 87.0% and a specificity of 86.7%. The separation of treated neuroblastoma patients from treated Wilms tumor patients' yielded comparable results with an accuracy of 83.8%. We furthermore identified the antigens that contribute most to the differentiation between both tumor types. The analysis of these antigens revealed that neuroblastoma was considerably more immunogenic than Wilms tumor. The reported antigens have not been found to be relevant for comparative analyses between other tumors and controls. In summary, neuroblastoma appears as a highly immunogenic tumor as demonstrated by the extended number of antigens that separate this tumor from Wilms tumor. KW - Heparan-sulfate KW - N-Myc KW - Serum autoantibodies KW - Suppressors EXT1 KW - Neuro-blastoma KW - Allelic loss KW - Lung-cancer KW - Children KW - Amplification KW - Therapy Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-133794 VL - 6 IS - 12 ER - TY - THES A1 - Röschert, Isabelle T1 - Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma T1 - Aurora-A verhindert Transkriptions-Replikationskonflikte in MYCN-amplifizierten Neuroblastomen N2 - Neuroblastoma is the most abundant, solid, extracranial tumor in early childhood and the leading cause of cancer-related childhood deaths worldwide. Patients with high-risk neuroblastoma often show MYCN-amplification and elevated levels of Aurora-A. They have a low overall survival and despite multimodal therapy options a poor therapeutic prognosis. MYCN-amplified neuroblastoma cells depend on Aurora-A functionality. Aurora-A stabilizes MYCN and prevents it from proteasomal degradation by competing with the E3 ligase SCFFBXW7. Interaction between Aurora-A and MYCN can be observed only in S phase of the cell cycle and activation of Aurora-A can be induced by MYCN in vitro. These findings suggest the existence of a profound interconnection between Aurora-A and MYCN in S phase. Nevertheless, the details remain elusive and were investigated in this study. Fractionation experiments show that Aurora-A is recruited to chromatin in S phase in a MYCN-dependent manner. Albeit being unphosphorylated on the activating T288 residue, Aurora-A kinase activity was still present in S phase and several putative, novel targets were identified by phosphoproteomic analysis. Particularly, eight phosphosites dependent on MYCN-activated Aurora-A were identified. Additionally, phosphorylation of serine 10 on histone 3 was verified as a target of this complex in S phase. ChIP-sequencing experiments reveal that Aurora-A regulates transcription elongation as well as histone H3.3 variant incorporation in S phase. 4sU-sequencing as well as immunoblotting demonstrated that Aurora-A activity impacts splicing. PLA measurements between the transcription and replication machinery revealed that Aurora-A prevents the formation of transcription-replication conflicts, which activate of kinase ATR. Aurora-A inhibitors are already used to treat neuroblastoma but display dose-limiting toxicity. To further improve Aurora-A based therapies, we investigated whether low doses of Aurora-A inhibitor combined with ATR inhibitor could increase the efficacy of the treatment albeit reducing toxicity. The study shows that the combination of both drugs leads to a reduction in cell growth as well as an increase in apoptosis in MYCN-amplified neuroblastoma cells, which is not observable in MYCN non-amplified neuroblastoma cells. This new approach was also tested by a collaboration partner in vivo resulting in a decrease in tumor burden, an increase in overall survival and a cure of 25% of TH-MYCN mice. These findings indicate indeed a therapeutic window for targeting MYCN-amplified neuroblastoma. N2 - Das Neuroblastom ist der häufigste, solide, extrakranielle Tumor der frühesten Kindheit und die häufigste mit Krebs verbundene Todesursache von Kleinkindern weltweit. Patienten mit geringerer Überlebenswahrscheinlichkeit und schlechterer Therapieprognose zeigen oft eine MYCN-Amplifikation und erhöhte Mengen von Aurora-A. Aurora-A ist eine Serin/Threonin-Protein Kinase, die wichtige mitotische Prozesse reguliert. Aurora-A stabilisiert MYCN und verhindert dadurch den proteasomalen Abbau von MYCN. Die Interaktion zwischen Aurora-A und MYCN ist S Phasen-spezifisch und MYCN ist in vitro in der Lage, durch seine Bindung Aurora-A zu aktivieren. Die Funktionen und Prozesse, die von Aurora-A in der S Phase reguliert werden, sind noch nicht hinreichend untersucht und daher Gegenstand dieser Dissertation. Zell-Fraktionierungen zeigen, dass Aurora-A in der S Phase in einer MYCN-abhängigen Weise an das Chromatin gebunden ist. Phosphoproteom-Analysen mittels Massenspektrometrie identifizierten zahlreiche neue Substrate von Aurora-A, sowie acht Substrate von MYCN-aktiviertem Aurora-A. Zusätzlich konnte gezeigt werden, dass Histon 3 Serin 10 von Aurora-A in Abhängigkeit von MYCN in S Phase phosphoryliert wird. ChIP-Sequenzierungen zeigen, dass Aurora-A die Elongation der Transkription und den Einbau der Histone Variante H3.3 in S Phase beeinflusst. 4sU-Sequenzierung sowie Immunoblots zeigen einen Zusammenhang zwischen der Aktivität von Aurora-A und dem Spleißosom in der S Phase. Zusätzlich konnte mittels PLA nachgewiesen werden, dass Aurora-A die Entstehung von Transkriptions-Replikationskonflikten verhindert, die andernfalls die Kinase ATR aktivieren würden. Aurora-A Inhibitoren wurden unter anderem zur Therapie von Neuroblastomen eingesetzt, allerdings ist die Dosis des Aurora-A Inhibitors durch die hohe Toxizität limitiert, was die Effizienz der Therapie stark beeinträchtigt. Daher wurde untersucht, ob die gleichzeitige Gabe von geringeren Mengen Aurora-A Inhibitor in Kombination mit einem ATR Inhibitor zur Therapie geeignet ist. In vitro konnte gezeigt werden, dass die Kombination beider Inhibitoren das Zellwachstum reduziert und das MYCN-amplifizierte Zellen im Vergleich zu MYCN nicht-amplifizierten Zellen verstärkt durch Apoptose sterben. Durch einen Kollaborationspartner konnte die Kombination der beiden Inhibitoren an Mäusen getestet werden. Die mit der Kombination behandelten Mäuse, zeigen ein deutlich reduziertes Tumorwachstum, sowie längeres Überleben. Somit stellt diese Kombination ein therapeutisches Fenster dar und könnte zur Behandlung von Neuroblastompatienten genutzt werden. KW - Neuroblastom KW - Aurora-A KW - MYCN KW - neuroblastoma Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-243037 ER - TY - JOUR A1 - Rose, Kathleen M. A1 - Szopa, Jan A1 - Han, Fu-Sheng A1 - Cheng, Yung-Chi A1 - Richter, Arndt A1 - Scheer, Ulrich T1 - Association of DNA topoisomerase I and RNA polymerase I: A possible role for topoisomerase I in ribosomal gene transcription N2 - RNA polymerase I preparations purified from a rat hepatoma contained DNA topoisomerase activity. The DNA topoisomerase associated with the polymerase had an Mr of 110000, required Mg2+ but not ATP, and was recognized by anti-topoisomerase I antibodies. When added to RNA polymerase I preparations containing topoisomerase activity, anti-topoisomerase I antibodies were able to inhibit the DNA relaxing activity of the preparation as well as RNA synthesis in vitro. RNA polymerase II prepared by analogous procedures did not contain topoisomerase activity and was not recognized by the antibodies. The topoisomerase I: polymerase I complex was reversibly dissociated by column chromatography on Sephacryl S200 in the presence of 0.25 M (NH4hS04. Topoisomerase I was immunolocalized in the transcriptionally active ribosomal gene complex containing RNA polymerase I in situ. These data indicate that topoisomerase I and RNA polymerase I are tightly complexed both in vivo and in vitro, and suggest a role for DNA topoisomerase I in the transcription of ribosomal genes. Y1 - 1988 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-33901 ER - TY - JOUR A1 - Tomei, Sara A1 - Adams, Sharon A1 - Uccellini, Lorenzo A1 - Bedognetti, Davide A1 - De Giorgi, Valeria A1 - Erdenebileg, Narnygerel A1 - Libera Ascierto, Maria A1 - Reinboth, Jennifer A1 - Liu, Qiuzhen A1 - Bevilacqua, Generoso A1 - Wang, Ena A1 - Mazzanti, Chiara A1 - Marincola, Francesco M. T1 - Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population JF - Medical Oncology N2 - HRAS belongs to the RAS genes superfamily. RAS genes are important players in several human tumors and the single-nucleotide polymorphism rs12628 has been shown to contribute to the risk of bladder, colon, gastrointestinal, oral, and thyroid carcinoma. We hypothesized that this SNP may affect the risk of cutaneous melanoma as well. HRAS gene contains a polymorphic region (rs112587690), a repeated hexanucleotide -GGGCCT- located in intron 1. Three alleles of this region, P1, P2, and P3, have been identified that contain two, three, and four repeats of the hexanucleotide, respectively. We investigated the clinical impact of these polymorphisms in a case–control study. A total of 141 melanoma patients and 118 healthy donors from the North America Caucasian population were screened for rs12628 and rs112587690 polymorphisms. Genotypes were assessed by capillary sequencing or fragment analysis, respectively, and rs12628 CC and rs112587690 P1P1 genotypes significantly associated with increased melanoma risk (OR = 3.83, p = 0.003; OR = 11.3, p = 0.033, respectively), while rs112587690 P1P3 frequency resulted significantly higher in the control group (OR = 0.5, p = 0.017). These results suggest that rs12628 C homozygosis may be considered a potential risk factor for melanoma development in the North American population possibly through the linkage to rs112587690. KW - HRAS KW - polymorphism KW - melanoma KW - rs12628 KW - rs112587690 Y1 - 2012 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-126834 VL - 29 IS - 5 ER - TY - THES A1 - Heidbreder, Meike T1 - Association and Activation of TNF-Receptor I Investigated with Single-Molecule Tracking and Super-Resolution Microscopy in Live Cells T1 - Assoziierung und Aktivierung des TNF-Rezeptor I untersucht mit Einzelmolekül-Tracking und hochauflösender Mikroskopie in lebenden Zellen N2 - Cellular responses to outer stimuli are the basis for all biological processes. Signal integration is achieved by protein cascades, recognizing and processing molecules from the environment. Factors released by pathogens or inflammation usually induce an inflammatory response, a signal often transduced by Tumour Necrosis Factor alpha (TNF). TNFα receptors TNF-R1 and TNF-R2 can in turn lead to apoptosis or proliferation via NF-B. These processes are closely regulated by membrane compartimentalization, protein interactions and trafficking. Fluorescence microscopy offers a reliable and non-invasive method to probe these cellular events. However, some processes on a native membrane are not resolvable, as they are well below the diffraction limit of microscopy. The recent development of super-resolution fluorescence microscopy methods enables the observation of these cellular players well below this limit: by localizing, tracking and counting molecules with high spatial and temporal resolution, these new fluorescence microscopy methods offer a previously unknown insight into protein interactions at the near-molecular level. Direct stochastic optical reconstruction microscopy (dSTORM) utilizes the reversible, stochastic blinking events of small commercially available fluorescent dyes, while photoactivated localization microscopy (PALM) utilizes phototransformation of genetically encoded fluorescent proteins. By photoactivating only a small fraction of the present fluorophores in each observation interval, single emitters can be localized with high precision and a super-resolved image can be reconstructed. Quantum Dot Triexciton imaging (QDTI) utilizes the three-photon absorption (triexcitonic) properties of quantum dots (QD) and to achieve a twofold resolution increase using conventional confocal microscopes. In this thesis, experimental approaches were implemented to achieve super-resolution microscopy in fixed and live-cells to study the spatial and temporal dynamics of TNF and other cellular signaling events. We introduce QDTI to study the three-dimensional cellular distribution of biological targets, offering an easy method to achieve resolution enhancement in combination with optical sectioning, allowing the preliminary quantification of labeled proteins. As QDs are electron dense, QDTI can be used for correlative fluorescence and transmission electron microscopy, proving the versatility of QD probes. Utilizing the phototransformation properties of fluorescent proteins, single-receptor tracking on live cells was achieved, applying the concept of single particle tracking PALM (sptPALM) to track the dynamics of a TNF-R1-tdEos chimera on the membrane. Lateral receptor dynamics can be tracked with high precision and the influences of ligand addition or lipid disruption on TNF-R1 mobility was observed. The results reveal complex receptor dynamics, implying internalization processes in response to TNFα stimulation and a role for membrane domains with reduced fluidity, so-called lipid raft domains, in TNF-R1 compartimentalization prior or post ligand induction. Comparisons with previously published FCS data show a good accordance, but stressing the increased data depth available in sptPALM experiments. Additionally, the active transport of NF-κB-tdEos fusions was observed in live neurons under chemical stimulation and/or inhibition. Contrary to phototransformable proteins that need no special buffers to exhibit photoconversion or photoactivation, dSTORM has previously been unsuitable for in vivo applications, as organic dyes relied on introducing the probes via immunostaining in concert with a reductive, oxygen-free medium for proper photoswitching behaviour. ATTO655 had been previously shown to be suitable for live-cell applications, as its switching behavior can be catalyzed by the reductive environment of the cytoplasm. By introducing the cell-permeant organic dye via a chemical tag system, a high specificity and low background was achieved. Here, the labeled histone H2B complex and thus single nucleosome movements in a live cell can be observed over long time periods and with ~20 nm resolution. Implementing these new approaches for imaging biological processes with high temporal and spatial resolution provides new insights into the dynamics and spatial heterogeneities of proteins, further elucidating their function in the organism and revealing properties that are usually only detectable in vitro.   N2 - Zelluläre Antworten auf externe Stimuli sind die Basis aller biologischer Prozesse. Die Integration dieser Signale wird dabei von Proteinkaskaden ausgeführt, welche Moleküle aus der Umgebung wahrnehmen und verarbeiten. Faktoren, welche von Pathogenen oder während einer Entzündung freigesetzt werden, induzieren für gewöhnlich eine Entzündungsantwort, eine Reaktion, die oft vom Tumornekrosefaktor alpha (TNFα) vermittelt wird. Die TNFα Rezeptoren TNF-R1 und TNF-R2 vermitteln nach Ligandenbinding Apoptose oder Zellproliferation durch NF-kB. Diese Prozesse sind engmaschig durch Membrankompartimentierung, Proteininteraktionen und -transport reguliert. Fluoreszenzmikroskopie bietet eine zuverlässige, nicht-invasive Methode um diese zellulären Prozesse zu untersuchen. Allerdings sind einige Prozesse innerhalb einer nativen Membran nicht auflösbar, da sie weit unterhalb der Beugungsgrenze der Lichtmikroskopie stattfinden. Die jüngste Entwicklung der hochauflösenden Fluoreszenzmikroskopiemethoden erlaubt die Beobachtung dieser zellulären Abläufe auf molekularer Ebene: durch das Lokalisieren, Verfolgen und Zählen von Molekülen mit hoher räumlicher und zeitlicher Auflösung bieten diese neuen Fluoreszenzmethoden bisher unbekannte Einblicke in Proteininteraktionen. Direkte stochastische optische Rekonstruktionsmikroskopie (dSTORM) nutzt die reversiblen, stochastischen Ereignisse von kleinen blinkenden, kommerziell erhältlichen Fluoreszenzfarbstoffen, während die photoaktivierte Lokalisationsmikroskopie (PALM) die Phototransformation fluoreszierenden Proteinen nutzt. Durch das Photoaktivieren lediglich eines kleinen Bruchteils der Fluorophore innerhalb eines Zeitintervalls können einzelne Emitter mit hoher Genauigkeit lokalisiert und ein hochaufgelöstes Bild daraus rekonstruiert werden. Quantum Dot Triexciton Imaging (QDTI) nutzt die Drei-Photonen-Absorption von Quantenpunkten um eine zweifache Auflösungserhöhung mittels eines Konfokalmikroskopes zu erreichen. In dieser Arbeit wurden experimentelle Ansätze zur hochauflösenden Mikroskopie an fixierten und lebenden Zellen implementiert, um die räumliche und zeitliche Dynamik von TNF und anderen zellulären Signalwegen zu untersuchen. Zur Analyse der dreidimensionalen, zellulären Verteilung von biologischen Zielen stellen wir QDTI vor, welches eine einfache Methode zur Verbesserung der Auflösung an Konfokalmikroskopen in Kombination mit optischen Schnitten darstellt. Dies ermöglicht die vorläufige Quantifizierung von markierten Proteinen. Da QDs eine hohe Elektronendichte besitzen kann QDTI auch für korrelative Fluoreszenz- und Transmissionselektronenmikroskopie genutzt werden, was die Vielseitigkeit der QD-Sonden verdeutlicht. Mit Hilfe des single-particle tracking PALM (sptPALM) Konzepts konnten einzelne Rezeptormoleküle verfolgt werden, um die Dynamiken einer TNF-R1-tdEos Chimäre auf der Membran zu beobachten. Die laterale Rezeptordynamik kann hier mit hoher Präzision gemessen, und die Einflüsse auf die TNF-R1-Mobilität konnte nach Ligandenzugabe oder die Störung der Membranzusammensetzung analysiert werden. Die Ergebnisse zeigen eine komplexe Rezeptordynamik und lassen sowohl auf Internalisierungsprozesse in Reaktion auf TNFα-Stimulation, als auch auf eine wichtige Rolle von Membrandomänen mit eingeschränkter Fluidität in der TNF-R1 Kompartimentierung während der Ligandenbindung schließen. Zusätzlich wurde der aktive Transport von NF-kB-tdEos Fusionsproteinen in lebenden Neuronen unter chemischer Stimulierung bzw. Inhibierung untersucht. Im Gegensatz zu phototransformierbaren Proteinen, die keine speziellen Puffer zur Photokonversion oder Photoaktivierung benötigen, war dSTORM bisher für in vivo Anwendungen ungeeignet, da organische Farbstoffe auf die Einführung über Immunfärbung in Kombination mit einem reduktiven, Sauerstoff-freiem Medium für korrektes Photoschalten angewiesen waren. ATTO655 wurde zuvor als geeignet für die Anwendung in lebenden Zellen eingestuft, da das Schaltverhalten durch die reduktive Umgebung des Zytoplasmas katalysiert werden kann. Durch die Einführung von membranpermeablen organischen Farbstoffen über ein chemisches Markierungssystem konnte eine hohe Spezifität und ein geringer Hintergrund erreicht werden. Hier konnte durch die Markierung des Histon H2B Komplexes die Bewegung einzelner Nukleosome in lebenden Zellen über lange Zeiträume mit einer Auflösung von ~20 nm beobachtet werden. Die Umsetzung dieser neuen Ansätze für die Darstellung biologischer Prozesse mit hoher zeitlicher und räumlicher Auflösung liefert neue Einblicke in die Dynamiken und die räumliche Heterogenität von Proteinen und enthüllt Funktionen im Organismus und beleuchtet Eigenschaften, die sonst nur in vitro nachweisbar wären. KW - Fluoreszenzmikrosopie KW - Tumor-Nekrose-Faktor KW - Hochauflösendes Verfahren KW - sptPALM KW - dSTORM KW - PALM KW - QDTI KW - TNF-R1 KW - TNF-R2 Y1 - 2012 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-73191 ER - TY - JOUR A1 - Fischer, Dagmar A1 - Weißenberger, Dieter A1 - Scheer, Ulrich T1 - Assigning functions to nucleolar structures N2 - Nucleoli provide the fascinating possibility of linking morphologically distinct structures such as those seen in the electron microscope with biochemical f eatures of the formation and step wise maturation of ribosomes. Localization of proteins by immunocytochemistry and of rRNA genes and their transcripts by in situ hybridization has greatly improved our understanding of the structural-functional relationships of the nucleolus. The present review describes some recent results obtained by electron microscopic in situ hybridization and argues that this approach has the potential to correlate each step of the complex pre-rRNA maturation pathway with nucleolar structures. Evidence is accumulating that the nucleolus-specific U3 snRNPs (small nuclear ribonucleoprotein particles) participate in rRNA processing events, similar to the role played by the nucleoplasmic snRNPs in mRNA maturation. The intranucleolar distribution of U3 snRNA is consistent with the view that it is involved in both early and late stages of pre-rRNA processing. Y1 - 1991 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-34258 ER - TY - JOUR A1 - Dabauvalle, Marie-Christine A1 - Scheer, Ulrich T1 - Assembly of nuclear pore complexes in Xenopus egg extract N2 - No abstract available Y1 - 1991 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-41194 ER - TY - JOUR A1 - Gupta, Shishir K. A1 - Srivastava, Mugdha A1 - Osmanoglu, Özge A1 - Xu, Zhuofei A1 - Brakhage, Axel A. A1 - Dandekar, Thomas T1 - Aspergillus fumigatus versus genus Aspergillus: conservation, adaptive evolution and specific virulence genes JF - Microorganisms N2 - Aspergillus is an important fungal genus containing economically important species, as well as pathogenic species of animals and plants. Using eighteen fungal species of the genus Aspergillus, we conducted a comprehensive investigation of conserved genes and their evolution. This also allows us to investigate the selection pressure driving the adaptive evolution in the pathogenic species A. fumigatus. Among single-copy orthologs (SCOs) for A. fumigatus and the closely related species A. fischeri, we identified 122 versus 50 positively selected genes (PSGs), respectively. Moreover, twenty conserved genes of unknown function were established to be positively selected and thus important for adaption. A. fumigatus PSGs interacting with human host proteins show over-representation of adaptive, symbiosis-related, immunomodulatory and virulence-related pathways, such as the TGF-β pathway, insulin receptor signaling, IL1 pathway and interfering with phagosomal GTPase signaling. Additionally, among the virulence factor coding genes, secretory and membrane protein-coding genes in multi-copy gene families, 212 genes underwent positive selection and also suggest increased adaptation, such as fungal immune evasion mechanisms (aspf2), siderophore biosynthesis (sidD), fumarylalanine production (sidE), stress tolerance (atfA) and thermotolerance (sodA). These genes presumably contribute to host adaptation strategies. Genes for the biosynthesis of gliotoxin are shared among all the close relatives of A. fumigatus as an ancient defense mechanism. Positive selection plays a crucial role in the adaptive evolution of A. fumigatus. The genome-wide profile of PSGs provides valuable targets for further research on the mechanisms of immune evasion, antimycotic targeting and understanding fundamental virulence processes. KW - molecular evolution KW - phylogenetic analysis KW - adaptation KW - recombination KW - positive selection KW - human pathogenic fungi KW - genus Aspergillus KW - Aspergillus fumigatus Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-246318 SN - 2076-2607 VL - 9 IS - 10 ER - TY - JOUR A1 - Srivastava, Mugdha A1 - Bencurova, Elena A1 - Gupta, Shishir K. A1 - Weiss, Esther A1 - Löffler, Jürgen A1 - Dandekar, Thomas T1 - Aspergillus fumigatus challenged by human dendritic cells: metabolic and regulatory pathway responses testify a tight battle JF - Frontiers in Cellular and Infection Microbiology N2 - Dendritic cells (DCs) are antigen presenting cells which serve as a passage between the innate and the acquired immunity. Aspergillosis is a major lethal condition in immunocompromised patients caused by the adaptable saprophytic fungus Aspergillus fumigatus. The healthy human immune system is capable to ward off A. fumigatus infections however immune-deficient patients are highly vulnerable to invasive aspergillosis. A. fumigatus can persist during infection due to its ability to survive the immune response of human DCs. Therefore, the study of the metabolism specific to the context of infection may allow us to gain insight into the adaptation strategies of both the pathogen and the immune cells. We established a metabolic model of A. fumigatus central metabolism during infection of DCs and calculated the metabolic pathway (elementary modes; EMs). Transcriptome data were used to identify pathways activated when A. fumigatus is challenged with DCs. In particular, amino acid metabolic pathways, alternative carbon metabolic pathways and stress regulating enzymes were found to be active. Metabolic flux modeling identified further active enzymes such as alcohol dehydrogenase, inositol oxygenase and GTP cyclohydrolase participating in different stress responses in A. fumigatus. These were further validated by qRT-PCR from RNA extracted under these different conditions. For DCs, we outlined the activation of metabolic pathways in response to the confrontation with A. fumigatus. We found the fatty acid metabolism plays a crucial role, along with other metabolic changes. The gene expression data and their analysis illuminate additional regulatory pathways activated in the DCs apart from interleukin regulation. In particular, Toll-like receptor signaling, NOD-like receptor signaling and RIG-I-like receptor signaling were active pathways. Moreover, we identified subnetworks and several novel key regulators such as UBC, EGFR, and CUL3 of DCs to be activated in response to A. fumigatus. In conclusion, we analyze the metabolic and regulatory responses of A. fumigatus and DCs when confronted with each other. KW - infection KW - dendritic cells KW - Aspergillus fumigalus KW - metabolic modelling KW - signalling Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-201368 VL - 9 ER - TY - THES A1 - Hauff, Cornelia T1 - Aspects of the mode of action of bispecific T cell engager (BiTE) antibodies T1 - Wirkmechanismus eines bispezifischen T cell engager Antikörpers N2 - Bispecific T cell engager (BiTE) display a novel design among the class of bispecific antibodies and hold great promise to fight diverse cancers. BiTE molecules consist of two different binding entities derived from two human IgG antibodies connected by a short peptide linker. Their binding arms are directed against the CD3e chain of the T cell receptor on T cells and against an antigen that is specific for (e.g., CD19 for lymphoma in MT103) or over-expressed on (e.g., EpCAM for epithelial cancer in MT110) tumor cells. Without requirement for pre- or co-stimulation, BiTE molecules efficiently redirect CD3+ T cells towards tumor cells expressing the relevant target antigen. Only a BiTE molecule simultaneously bound to both tumor cell and T cell activates the T cell to exert its cytolytic function resulting in tumor cell death. In T cells stimulated with both BiTE and target cells, elevated levels of caspase activation and increased expression of cytotoxic and signaling proteins are observed. These include cytolytic proteins granzyme B and perforin, activation markers CD69 and CD25 and adhesion molecules CD2 and LFA-1. Activated T cells secrete the usual mix of cytokines, among them pro-inflammatory cytokines IFN-g and TNF-a. The membrane of tumor cells expressing the relevant target antigen is perforated during the attack of BiTE-stimulated effector cells as can be concluded from adenylate kinase release from the cytosol of tumor cells. Ca2+-chelator EGTA completely blocked BiTE-mediated activation of caspases and tumor cell lysis. As perforin is strictly Ca2+-dependent, a major role for this pore-forming protein is assumed for the elimination of tumor cells via BiTE-stimulated T cells. Granzyme B and caspases are main players in BiTE-mediated elimination of tumor cells. Inhibitors of granzyme B or caspases reduce or block, respectively the activation of caspases. However, other signals of apoptosis (cleavage of PARP and fragmentation of DNA) were only reduced by granzyme B inhibitor or caspase inhibitor. Most interestingly, the lytic capacity of BiTE molecules was not impaired by granzyme B inhibitor or caspase inhibitor. It seems that there is no requirement for granzyme B and caspases to be present simultaneously. Instead the data presented provide evidence that they can be replaced one at a time by related proteins. Pre-incubation of effector cells with the glucocorticoids dexamethasone or methylprednisolone resulted in markedly decreased secretion of cytokines by T cells yet only a small reduction in the expression of activation markers and adhesion molecules on T cells and specific lysis of tumor cells upon BiTE stimulation. Soluble factors secreted in an undirected manner by BiTE-stimulated T cells do not mediate tumor cell death by themselves. Bystander cells negative for the antigen that is recognized by the BiTE molecule will not be compromised by BiTE activity. The cytokine TGF-b reduced proliferation as well as granzyme B and perforin expression of BiTE-stimulated T cells. Redirected lysis by BiTE-activated T cells was also decreased under the influence of TGF-b, however lysis was still performed at a reasonable rate (72 % of target cells). TGF-b does not exert a deleterious effect on lytic potential of BiTE-stimulated T cells. The minimal anticipated biological effect level for the BiTE MT110 was determined for the entry of MT110 into phase I clinical studies. Experiments analyzing redirected lysis of tumor cells, expression of activation marker CD25 and cytokine release by T cells revealed a MABEL value of 50 pg/ml for MT110. N2 - Bispecific T cell engager stellen mit ihrem neuartigen Design eine eigene Gruppe unter den bispezifischen Antikörpern dar und zeigen sich vielversprechend im Kampf gegen unter-schiedliche Krebsarten. BiTE Moleküle bestehen aus zwei unterschiedlichen Bindungsstellen, die von zwei humanen IgG Antikörpern abgeleitet sind und durch einen kurzen Peptidlinker verbunden sind. Die Bindungsstellen sind gerichtet gegen die CD3e Kette des T-Zell-Rezeptors auf T-Zellen und gegen ein Antigen, das auf den Tumorzellen ausschließlich (CD19 bei Lymphomen in MT103) oder in erhöhtem Maße (EpCAM bei epithelialem Krebs in MT110) exprimiert wird. BiTE Moleküle richten CD3+ T-Zellen gegen Tumorzellen, die das relevante Zielantigen präsentieren. Dabei sind sie nicht auf Vor- oder Kostimulation angewiesen. Nur wenn das BiTE Molekül gleichzeitig an Tumorzelle und T-Zelle gebunden ist, aktiviert es die T-Zelle zytolytisch zu wirken und die Tumorzelle zu töten. T-Zellen, die mit BiTE und zugleich Targetzellen stimuliert wurden, zeigen erhöhte Raten von Caspaseaktivierung und vermehrte Expression von zytotoxischen und Signalproteinen. Diese beinhalten die zytolytischen Proteine Granzyme B und Perforin, die Aktivierungs-marker CD69 und CD25 und die Adhäsionsmoleküle CD2 und LFA-1. Aktivierte T-Zellen sezernieren die übliche Mischung an Zytokinen, darunter die pro-inflammatorischen Zytokine IFN-g und TNF-a. Die Freisetzung von Adenylatkinase aus dem Zytosol von Tumorzellen lässt darauf schließen, dass die Membran von Tumorzellen, die das relevante Zielantigen exprimieren, während dem Angriff von BiTE-stimulierten Effektorzellen durchlöchert wird. Der Ca2+ Chelator EGTA verhinderte die BiTE-vermittelte Aktivierung von Caspasen und Lyse von Tumorzellen vollständig. Da Perforin in Abhängigkeit von Ca2+ wirkt, wird für dieses porenbildende Protein eine entscheidende Rolle in der Beseitigung von Tumorzellen mittels BiTE-stimulierter T-Zellen angenommen. Granzyme B und Caspasen sind die Hauptakteure in der BiTE-vermittelten Beseitigung von Tumorzellen. Inhibitoren von Granzyme B oder den Caspasen vermindern bzw. hemmen die Aktivierung von Caspasen. Andere Apoptosesignale (PARP-Spaltung und DNA-Fragmentierung) werden von Granzyme B- oder Caspase-Inhibitoren jedoch lediglich reduziert. Bemerkenswerterweise wurde die lytische Kapazität von BiTE Molekülen durch einen Granzyme B- oder Caspase-Inhibitor nicht beeinträchtigt. Es scheint, dass keine Notwendigkeit für die gleichzeitige Anwesenheit von Granzyme B und Caspasen besteht. Stattdessen erbringen die vorgestellten Ergebnisse einen Hinweis dafür, dass diese Proteine jeweils einzeln durch verwandte Proteine ersetzt werden können. Präinkubation von Effektorzellen mit den Glucocorticoiden Dexamethason oder Methylpred-nisolon bewirkte eine deutlich verminderte Zytokinsekretion von T-Zellen, jedoch nur eine geringe Abnahme der Expression von Aktivierungsmarkern und Adhäsionsmolekülen auf T-Zellen und der spezifischen Lyse von Tumorzellen in Folge von BiTE-Stimulierung. Lösliche Faktoren, die von BiTE-stimulierten T-Zellen nicht zielgerichtet abgegeben werden, vermitteln keine Lyse von Tumorzellen. Zellen, die sich in der Nachbarschaft des Tumors befinden, aber das Antigen nicht exprimieren, das vom BiTE Moleküle erkannt wird, werden daher durch BiTE Aktivität nicht in Mitleidenschaft gezogen. Das Zytokin TGF-b verminderte die Proliferation von BiTE-stimulierten T-Zellen sowie deren Expression von Granzyme B und Perforin. Die gerichtete Lyse von BiTE-aktivierten T-Zellen war unter dem Einflusss von TGF-b ebenfalls vermindert. Trotzdem erreichten die Lysisraten Werte von 72 %. TGF-b übt keinen schädlichen Effekt auf das lytische Potential von BiTE-stimulierten T-Zellen aus. Die MT110-Konzentration, bei der der geringste biologische Effekt erwartet wird, wurde für den Eintritt von MT110 in klinische Studien der Phase I bestimmt. Auf Grundlage von Experimenten zur gerichteten Lyse von Tumorzellen, zur Expression des Aktivierungsmarker CD25 auf T-Zellen und zu Freisetzung von Zytokinen aus T-Zellen, ergab sich ein MABEL-Wert von 50 pg/ml für MT110. KW - Antikörper KW - Krebs KW - Therapie KW - T-Lymphozyt KW - bispezifische Antikörper KW - Krebstherapie KW - T cell KW - bispecific antibody KW - cancer therapy Y1 - 2009 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-48369 ER - TY - JOUR A1 - Müller, T. A1 - Dieckmann, T. A1 - Sebald, Walter A1 - Oschkinat, H. T1 - Aspects of receptor binding and signalling of interleukin-4 investigated by site-directed mutagenesis and NMR spectroscopy N2 - Cytokines are hormones that carry information from ceJI to ceH. This information is read from their surface upon binding to transmembrane receptors and by the subsequent initiation of receptor oligomerization. An inftuence on this process through mutagenesis on the hormone surface is highly desirab)e for medical reasons. However, an understanding of hormone-receptor interactions requires insight into the structural changes introduced by the mutations. In this line structural studies on human TL-4 and the medically important IL-4 antagonists YI24D and Y124G are presented. The site a.round YI24 is an important epitope responsible for the a.bility of 11-4 t.o ca.use a signal in the target cells. It is shown that the local main-chain structure around residue 124 in the variants remains unchanged. A strategy is presented here which allows the study of these types of proteins and their variants by NMR which does not require carbon Iabeiied sa.mples. KW - Biochemie KW - Interleukin-4 KW - protein structure KW - NMR KW - signal transduction Y1 - 1994 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-62444 ER -